Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Scott T. Micek, PharmD"'
Autor:
Hayley Motowski, MD, Daniel Ilges, PharmD, Nicholas Hampton, PharmD, Marin H. Kollef, MD, Scott T. Micek, PharmD
Publikováno v:
Critical Care Explorations, Vol 5, Iss 3, p e0867 (2023)
IMPORTANCE:. Hospital-acquired pneumonia (HAP) is the most common hospital-acquired infection, accounting for 22% of all nosocomial infections. The available studies to date have not attempted to assess whether confounding factors may account for the
Externí odkaz:
https://doaj.org/article/046c7f01855b421eac73e6f27e45a5a7
Autor:
Thomas J. Dilworth, PharmD, Lucas T. Schulz, PharmD, Scott T. Micek, PharmD, Marin H. Kollef, MD, Warren E. Rose, PharmD
Publikováno v:
Critical Care Explorations, Vol 4, Iss 7, p e0726 (2022)
OBJECTIVE:. β-lactams are the cornerstone of empiric and targeted antibiotic therapy for critically ill patients. Recently, there have been calls to use β-lactam therapeutic drug monitoring (TDM) within 24–48 hours after the initiation of therapy
Externí odkaz:
https://doaj.org/article/dbec365f4e5b4cd384caeda2d220cd69
Autor:
Richard F. Van Besien, MD, Nicholas Hampton, PharmD, Scott T. Micek, PharmD, Marin H. Kollef, MD, Maya Saranathan.
Publikováno v:
Medicine, Vol 101, Iss 20, p e29159 (2022)
Abstract. Much remains unknown about the impact of initial antibiotic adequacy on mortality in community onset bacterial pneumonia (COBP). Therefore, we performed a study to determine how the adequacy of initial antibiotic therapy affects in-hospital
Externí odkaz:
https://doaj.org/article/99dad2aad0024131912c88e49e799173